Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-02-11T21:35:53.661Z Has data issue: false hasContentIssue false
  • English
  • Français

An Investigation into the Effects of Azacyclonal on the Hallucinations of Chronic Schizophrenic Patients

Published online by Cambridge University Press:  08 February 2018

M. A. Hargreaves
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Frenquel, α-(4-piperidyl) benzhydrol hydrochloride, generically known as Azacyclonal hydrochloride was introduced commercially into this country in the early part of 1957 although it had already been available in the United States of America for several months previously. Sargant (1956) obtained a supply of Azacyclonal from America and in his paper on Chemical Tranquillizers he refers to Azacyclonal as “an interesting drug”. Azacyclonal was thought to be the first drug to possess a specific anti-hallucinatory effect.

Type
Original Articles
Information
Journal of Mental Science , Volume 105 , Issue 438 , January 1959 , pp. 210 - 214
Copyright
Copyright © Royal College of Psychiatrists, 1959 

References

Bettag, , et al., Presented to Meeting of Amer. Psych. Ass., Atlantic City, New Jersey, May, 1955.Google Scholar
Brown, , et al., J. Pharmacol., 1956, 118, 153.Google Scholar
Fabing, , Amer. Pract., 1955, 6, 1678.Google Scholar
Idem and Hawkins, , Dis. nerv. Syst., 1955, 16, 11.Google Scholar
Ferguson, , Antibiotic Med., and Clin. Therapy, 1956, 1, 75.Google Scholar
Gray, and Forrest, , Brit. med. J., 1958, 1, 374.CrossRefGoogle Scholar
Proctor, and Odland, , Dis. nerv. Syst., 1956, 17, 25.Google Scholar
Rinaldi, , et al., Amer. J. Psychiat., 1955, 112, 343.CrossRefGoogle Scholar
Sargant, , Brit. med. J., 1956, 1, 939.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.